Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.

460 . Mt Sinai J Med. 2002 May;69(3):148-55. Mt Sinai J Med. 2002. PMID: 12035074 Review. .

Cite . Lehnertz B, et al. Blood. 2021 Sep 9:blood.2021010745. doi: 10.1182/blood.2021010745. Online ahead of print. Blood. 2021. PMID: 34499717 .

510